Tweed Inc. announced Thursday it has begun research in conjunction with the University of Ottawa and Ryerson University that the company says will help build a better knowledge base about medical marijuana in Canada.
"With the new regulatory system in place, producers and researchers now have the stability to undertake research not possible in the past," Tweed CEO Chuck Rifici said in a statement. "These projects will shed insight into everything from ideal growing conditions to the very question of what makes medical marijuana an effective medicine."
All the research is being completed at Tweed’s facility in Smiths Falls.
The first experiments, with Ryerson, are looking into how the environment contributes to the cannabis plant’s health and productivity.
The University of Ottawa researchers will examine correlations between active ingredients in medical marijuana and strain effectiveness on selected ailments.
"This work has the potential to open up entire new avenues of research into medical marijuana and we look forward to working with Tweed to move the sector forward,” said University of Ottawa professor John Arnason in a statement.
Tweed (TSXV: TWD) said the research is an important part of the company’s strategic plans.